MedTrace Logo

MDR Vivacit-E Elevated Study

NCT07150221 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2026-04-01

No results posted yet for this study

Summary

The main objective of this study is to confirm long-term safety, performance, and clinical benefits of the Vivacit-E Vitamin E HXLPE Elevated Liners when used in primary total hip arthroplasty.

Conditions

  • Osteoarthritis (OA) of the Hip
  • Avascular Necrosis of Bone of Hip
  • Protrusio Acetabuli
  • Traumatic Arthropathy-Hip
  • Slipped Capital Femoral Epiphyses
  • Fused Hip
  • Fracture of Pelvis
  • Diastrophic Variant

Interventions

DEVICE

Vivacit-E Elevated Liners

Primary total hip arthroplasty

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-07
Primary Completion
2027-12-31
Completion
2027-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07150221 on ClinicalTrials.gov